Access Pathway

Program three of three

We open the door. Proven treatments and devices that can't get paid for. We publish the evidence and drive the coverage.

The first instance is my own reconstruction.

The implant has been FDA-cleared since 2022. The surgeons are here in Salt Lake. The literature runs five hundred plus cases abroad. And still: no billing code, no coverage, years of fighting for every inch.

That is not a technology failure. It is a pathway failure. A cleared device that nobody can bill for is, to a patient, the same as a device that does not exist.

Andrew Piskadlo, President and CEO

How the walk works

Three steps, and none of them are new.

This has been done before. Partial-hand prostheses got their own codes after one clinician-led push, and they are billable to Medicare as of this April. The path exists. Almost nobody walks it, because walking it is unglamorous, slow, and belongs to no single institution.

Step one

Publish the case

Find who needs it and prove it. Build the evidence record to a standard that survives review, then put it in the literature where a payer has to reckon with it.

Step two

Drive the code

A procedure nobody can bill is a procedure nobody performs. Take the evidence through the committees that assign the code, and stay in the room for the years it takes.

Step three

Open the coverage

The code is the lock. Coverage is the door. Once both open, the treatment reaches the people it was cleared for, and it stays reachable without us.

Two locks on the door

Regulation and awareness. We open both: find who needs it, prove it, code it.

And the playbook is not medical-only. Wherever institutional inertia strands proven technology, the walk is the same. The subject changes, the sequence does not.

Fund the pathway Bring us a stranded technology

This page is a summary. The full Access Pathway program page, with the regulatory route and intake criteria, is in production.